Moray Medical announced today that it has raised $3.3 million in seed funding led by 415 CAPITAL, which invested alongside a number of prominent medtech entrepreneurs.
Moray is developing the CoralTM system, a novel interventional robotics platform powered by microfluidics and an augmented reality (AR) digital user interface. While the platform promises to dramaticlly simplify a wide range of minimally invasive cardiovascular interventions, Moray is initially focused on the rapidly growing transcatheter mitral valve repair (TMVR) market.
“While transcatheter edge-to-edge repair (TEER), or clip therapy, is rapidly becoming the new clinical standard of care, the complexity and learning curve associated with current devices means that the vast majority of needy patients are being left untreated,” said Mark Barrish, CEO and Co-Founder of Moray Medical. “Our platform is aimed at empowering interventionalists at all skill levels to carry out these procedures in a cost-efficient manner to ensure that millions of additional sick patients get the life-saving treatment they deserve.”